Present mortality in Parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths-Reference-Cited by-同舟云学术

Present mortality in Parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths

Published:1976-09 Issue:3-4 Volume:38 Page:259-269
ISSN:0300-9564
Container-title:Journal of Neural Transmission
language:en
Short-container-title:J. Neural Transmission

Author:

Diamond S. G.,Markham Ch. H.

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://link.springer.com/content/pdf/10.1007/BF01249443.pdf

Reference9 articles.

1. Barbeau, A.: Six years of high-level levodopa therapy in severely akinetic parkinsonian patients. Arch. Neurol.33, 333?338 (1976).

2. Cotzias, G. C., Papavasiliou, P. S., Gellene, R.: Modification of parkinsonism?chronic treatment with L-dopa. N. Eng. J. Med.280, 337?345 (1969).

3. Diamond, S. G., Markham, C. H., Treciokas, L. J.: Long term experience with levodopa: efficacy, progression and mortality. Proc. Vth Int. Symp. Parkinson's Disease, Vienna 1975 (in press).

4. Hoehn, M. M., Yahr, M. D.: Parkinsonism: onset, progression and mortality. Neurology17, 427?442 (1967).

5. Kurland, L. T.: Epidemiology: incidence, geographic distribution and genetic considerations. In: Pathogenesis and Treatment of Parkinsonism (Field, W. S., ed.). Springfield, Ill.: Charles C Thomas. 1958.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Parkinson's Disease on Complications, Readmission Rates, and Costs of Care following Primary Total Knee Arthroplasty;The Journal of Knee Surgery;2020-05-27

2. Mortality in Levodopa-Treated Parkinson's Disease;Parkinson's Disease;2014

3. Disease modification in Parkinson’s disease: are we there yet with currently available therapies?;Neurodegenerative Disease Management;2012-08

4. Seniors with Parkinson's Disease: Initial Medical Treatment;Journal of Clinical Neurology;2010

5. Mortality in a population-based cohort of patients treated with antiparkinsonian drugs;Acta Neurologica Scandinavica;2009-01-29